Company Stellar Biotechnologies Inc Toronto S.E.
Equities
KLH
CA85855A2039
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 11/06/07 |
Michael Brooks
PSD | President | 46 | 31/08/15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 14/07/23 |
Blair Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/16 |
Gary Koppenjan
IRC | Investor Relations Contact | - | 31/12/18 |
Raj Puri
PRN | Corporate Officer/Principal | - | 22/06/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 06/06/19 |
Frank Oakes
BRD | Director/Board Member | 73 | 08/04/10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 22/05/23 |
Joan Chypyha
BRD | Director/Board Member | 57 | 22/05/23 |
Charles Olson
BRD | Director/Board Member | 66 | 22/05/23 |
Pardeep Nijhawan
FOU | Founder | 53 | 11/06/07 |
Carlo Sistilli
CHM | Chairman | 67 | 06/06/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,215,968 | 2,301,084 ( 71.55 %) | 0 | 71.55 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |